第2章 骨移植片替代物的市場

第3章 玻尿酸關節內補充市場

第4章 加工骨椎間設備市場

市場現狀

市場詳細分析

競爭概要

更許多競爭環境

市場佔有率

第5章 細胞濃縮系統市場

市場現狀

市場詳細分析

競爭概要

更許多競爭環境

市場佔有率

附錄：分析方法

附錄：簡稱、詞彙表

附錄：相關分析

圖表一覽

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Product Code: M360OB0026

Despite ongoing obstacles to growth, such as changes to treatment recommendations, challenging reimbursement environments, and negative publicity surrounding significant products, the US market for orthopedic biomaterials will show sustained and improving growth comparable to other large orthopedic markets.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for orthopedic biomaterials in the US across a 10-year period.

Questions Answered in This Report:

The BGS market continues to be negatively impacted by ongoing issues surrounding INFUSE, although the introduction of new products in the growth factor and other segments will help offset this trend.

Which material segments will benefit from declining use of growth factor products?

How will growth of the overall BGS market be impacted by this change in product mix?

What kind of indications should new growth factor products target in order to be successful in this market?

The recent and continuing introduction of products and expanded indications in the HA viscosupplementation market will drive market growth.

How will the introduction of new products help offset the negative recommendation against HA injections by the AAOS?

How will the nonknee market segment expand following the anticipated approval of these indications?

How will the introduction of a value-based care model impact HA viscosupplementation unit volumes?